down arrow

Vivanza Biosci.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: INE984E01035
  • NSEID:
  • BSEID: 530057
INR
2.28
-0.02 (-0.87%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 18.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

18.77 k (-51.14%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

20.02%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.57%

  • Poor long term growth as Operating profit has grown by an annual rate 13.09% of over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.05 times
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Reducing Promoter Confidence

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

INR 9 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

28

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.23

stock-summary
Return on Equity

1.83%

stock-summary
Price to Book

1.87

Revenue and Profits (1 Year):
Net Sales:
2 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-43.0%
0%
-43.0%
1 Year
-74.27%
0%
-74.27%
2 Years
-88.45%
0%
-88.45%
3 Years
-87.91%
0%
-87.91%
4 Years
-81.25%
0%
-81.25%
5 Years
74.05%
0%
74.05%

Vivanza Biosci. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.88%
EBIT Growth (5y)
13.09%
EBIT to Interest (avg)
0.47
Debt to EBITDA (avg)
2.49
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.35
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
3.26%
ROE (avg)
12.01%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
28
Price to Book Value
1.87
EV to EBIT
15.27
EV to EBITDA
15.27
EV to Capital Employed
1.39
EV to Sales
1.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.46%
ROE (Latest)
1.83%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Parth Hemant Parikh (19.77%)

Highest Public shareholder

Ashoka Metcast Limited (3.85%)

Individual Investors Holdings

71.21%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -77.13% vs 11.95% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -80.95% vs -54.35% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.50",
          "val2": "6.56",
          "chgp": "-77.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.12",
          "val2": "0.29",
          "chgp": "-58.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.10",
          "chgp": "-10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.04",
          "val2": "0.21",
          "chgp": "-80.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.00%",
          "val2": "4.42%",
          "chgp": "3.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -67.72% vs 355.41% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -63.16% vs 216.67% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.44",
          "val2": "16.85",
          "chgp": "-67.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.47",
          "val2": "0.91",
          "chgp": "-48.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.18",
          "val2": "0.22",
          "chgp": "-18.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.28",
          "val2": "0.76",
          "chgp": "-63.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.64%",
          "val2": "5.40%",
          "chgp": "3.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -70.35% vs 144.87% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -67.01% vs 38.57% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.94",
          "val2": "23.41",
          "chgp": "-70.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.59",
          "val2": "1.20",
          "chgp": "-50.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.27",
          "val2": "0.32",
          "chgp": "-15.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.32",
          "val2": "0.97",
          "chgp": "-67.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.50%",
          "val2": "5.13%",
          "chgp": "3.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 56.32% vs 71.25% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -8.33% vs 81.82% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27.84",
          "val2": "17.81",
          "chgp": "56.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.07",
          "val2": "0.66",
          "chgp": "62.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.41",
          "val2": "0.42",
          "chgp": "-2.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.55",
          "val2": "0.60",
          "chgp": "-8.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.84%",
          "val2": "3.71%",
          "chgp": "0.13%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1.50
6.56
-77.13%
Operating Profit (PBDIT) excl Other Income
0.12
0.29
-58.62%
Interest
0.09
0.10
-10.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.04
0.21
-80.95%
Operating Profit Margin (Excl OI)
8.00%
4.42%
3.58%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -77.13% vs 11.95% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -80.95% vs -54.35% in Dec 2023

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
5.44
16.85
-67.72%
Operating Profit (PBDIT) excl Other Income
0.47
0.91
-48.35%
Interest
0.18
0.22
-18.18%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.28
0.76
-63.16%
Operating Profit Margin (Excl OI)
8.64%
5.40%
3.24%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -67.72% vs 355.41% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -63.16% vs 216.67% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
6.94
23.41
-70.35%
Operating Profit (PBDIT) excl Other Income
0.59
1.20
-50.83%
Interest
0.27
0.32
-15.62%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.32
0.97
-67.01%
Operating Profit Margin (Excl OI)
8.50%
5.13%
3.37%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -70.35% vs 144.87% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -67.01% vs 38.57% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
27.84
17.81
56.32%
Operating Profit (PBDIT) excl Other Income
1.07
0.66
62.12%
Interest
0.41
0.42
-2.38%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.55
0.60
-8.33%
Operating Profit Margin (Excl OI)
3.84%
3.71%
0.13%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 56.32% vs 71.25% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -8.33% vs 81.82% in Mar 2023

stock-summaryCompany CV
About Vivanza Biosciences Ltd stock-summary
stock-summary
Vivanza Biosciences Ltd
Micro Cap
Miscellaneous
Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992. Head quartered in Gujarat, India, the Company came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.
Company Coordinates stock-summary
Company Details
403 Sarthik 2 Opp Rajpath Club, S G Highway Ahmedabad Gujarat : 380054
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai